Company Hosting Virtual KOL Panel Event Thursday, November 13th at 10:00 AM ETBOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Atea ...

Check the rationalized list of chapters and topics removed from the NCERT textbook. Focus on the revised curriculum for ...

Oral presentation of 96-week treatment and post-treatment data suggest best-in-class potential of pevifoscorvir sodium ...

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced two ...

Atea Pharmaceuticals (AVIR) announced the presentation of new modeling data predicting that the Company’s combination regimen of bemnifosbuvir, ...

Trial met primary endpoint, with statistically significant reductions in liver fat observed in all HU6 treatment groups –– In addition to ...

Check subject-wise list of topics and chapters removed from Class 9 Maths, Science, Social Science, English and Hindi syllabus. Know which portions to skip for CBSE Board Exam 2026 based on the latest ...

New Data From REZOLVE-AD Study Of Rezpegaldesleukin Presented In Late-Breaking Oral Abstract Presentation At ACAAI 2025 Annual Scientific Meeting. Statistically significant and clinically meaningful i ...

Twelve patients achieved stable disease, whereof five with disease control lasting over six months; this correlates with strong CD4⁺ and CD8⁺ memory T-cell expansionAs previously reported, the single ...

Dr. Simon Plyte, Biomunex's CSO, has been invited to present MAIT engagers preclinical data during an oral communication at 2025 SITC Annual meeting With a very attractive safety and efficacy ...

HanchorBio Inc., today announced that the preclinical data on HCB301, has been accepted for presentation at the 40th Annual ...